MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0014345
Phanicare Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹41.7 Cr
▼ 18% YoY
Net profit · FY 2024
₹53.28 Lakh
Net margin 1.3%
EBITDA · FY 2024
₹3.13 Cr
EBITDA margin 7.5%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.3 Cr
Issued & subscribed
Open charges
₹16.61 Cr
Satisfied ₹12.66 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
1
Provident fund records
About Phanicare Pharmaceuticals Private Limited
Data last updated:
Phanicare Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 October 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC041815. Its GSTIN is 36AADCP0774G1ZG (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.3 Cr. It is led by directors including Sumanth Karlapudi and Vishnuvardhan Reddy Devireddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.7 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹53.28 Lakh (net margin 1.3%) and EBITDA of ₹3.13 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 18% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Phanicare Pharmaceuticals. As per MCA filings, the company has open charges of ₹16.61 Cr and satisfied charges of ₹12.66 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it.
Phanicare Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0014345). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website phanicarepharma.com.
Company details
CIN U24239TG2003PTC041815
Registration Number 041815
Incorporation Date 07 October 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0014345
CIN history
Phanicare Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2003PTC041815. The current CIN is U24239TG2003PTC041815, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC041815 | Current |
| U24239AP2003PTC041815 | Previous |
Key People
Sumanth Karlapudi Director Vishnuvardhan Reddy Devireddy Director Mallikarjuna Reddy Venati Director Recognitions & Rankings of Phanicare Pharmaceuticals
Contact details
Phanicare Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is phanicarepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit S1 2nd Fllor 36 Square Building, Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, API Manufacturers
To see the full contact details of Phanicare Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Phanicare Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Phanicare Pharmaceuticals operates one associated brand: Phanicare Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides essential intermediates for pharmaceutical manufacturing with quality focus. | phanicarepharma.com |
Business activity
The main business activity of Phanicare Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Phanicare Pharmaceuticals Private Limited, buy the company report.
Financials of Phanicare Pharmaceuticals Private Limited
FY 2025 filings availablePhanicare Pharmaceuticals Private Limited reported revenue of ₹41.7 Cr (down 18% YoY) for FY 2024.
Revenue · FY 2024
₹41.7 Cr ▼ 18%
Net profit · FY 2024
₹53.28 Lakh margin 1.3%
EBITDA · FY 2024
₹3.13 Cr margin 7.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 19%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 8%
5 years · compounded
▲ 12%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Phanicare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Phanicare Pharmaceuticals Private Limited
Phanicare Pharmaceuticals has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumanth Karlapudi | Director | 01 Oct 2022 | 4 Years 0 Months | Current |
| Vishnuvardhan Reddy Devireddy Also directs: Popular Molecules Private Limited, Konar Organics Limited, Norrish Laboratories Private Limited and 1 more | Director | 08 Apr 2015 | 11 Years 6 Months | Current |
| Mallikarjuna Reddy Venati Also directs: Popular Molecules Private Limited, Konar Organics Limited, Norrish Laboratories Private Limited and 1 more | Director | 08 Apr 2015 | 11 Years 6 Months | Current |
| Padma Duvvuri | Director | 21 Apr 2016 | 10 Years 6 Months | Current |
Peer comparison
Phanicare Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allastir Private Limited | ₹42.05 Cr (FY 2024) | -3.0% | Chennai, Tamil Nadu, India | |||
| Keshar Emulsion Private Limited | ₹41.86 Cr (FY 2024) | -23.0% | Ahmedabad, Gujarat, India | |||
| Hi Tech Biosciences India Private Limited | ₹41.75 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Jai Lara Drugs Private Limited | ₹41.75 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Polydrug Laboratories Private Limited | ₹41.72 Cr (FY 2024) | 238.0% | Mumbai, Maharashtra, India | |||
| Phanicare Pharmaceuticals Private Limitedthis company | ₹41.7 Cr (FY 2024) | ₹53.28 Lakh | 1.3% | -18.0% | 1 | Hyderabad, Telangana, India |
| Qualikems Lifesciences Private Limited | ₹41.7 Cr (FY 2025) | 13.0% | Vadodara, Gujarat, India | |||
| Accrete Pharmaceuticals Private Limited | ₹41.49 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Assurgen Pharma Private Limited | ₹41.36 Cr (FY 2025) | -3.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Relixir Pharmaceuticals Private Limited | ₹41.19 Cr (FY 2023) | 48.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Phanicare Pharmaceuticals Private Limited, buy the company report.
Auditor
Phanicare Pharmaceuticals Private Limited is audited by G R Venkatesan & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G R Venkatesan & Company | FY 2023 | 0042631S |
Shareholding
The shareholding of Phanicare Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Phanicare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.61 Cr
Satisfied charges
₹12.66 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2023 | 100803453 | Axis Bank Limited | ₹3.5 Cr | Open | |
| 01 Jul 2020 | 100352373 | Axis Bank Limited | ₹1.61 Cr | Open | |
| 04 Oct 2018 | 100218126 | Axis Bank Limited | ₹11.5 Cr | Open | |
| 09 Apr 2020 | 100335511 | Axis Bank Limited | ₹40 Lakh | Satisfied | |
| 17 Jul 2017 | 100116100 | Axis Bank Limited | ₹3.5 Cr | Satisfied |
To see the full charge records of Phanicare Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Phanicare Pharmaceuticals Private Limited has 7 court cases on record: 3 filed by Phanicare Pharmaceuticals, 4 filed against it. All cases are disposed.
Total cases
7
Filed by the company
3
Filed against the company
4
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against Ms. Maven Life Sciences Pvt Ltd and 2 others | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ms. Maven Life Sciences Pvt Ltd | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh and 4 others | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Surbhi Transport Pvt Ltd | Disposed |
| High Court for State of Telangana | Court case (CRLP) | Filed against the company | Disposed |
To see the full case history of Phanicare Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Phanicare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Phanicare Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Employee growth
-50%
GST
Phanicare Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCP0774G1ZG | Telangana | Active | 01 Jul 2017 |
| 37AADCP0774G2ZD | Andhra Pradesh | Active | 27 Jun 2018 |
To see the full GST registrations and return filing status of Phanicare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Phanicare Pharmaceuticals Private Limited has 10 board changes on record since 2015: 4 appointments and 6 cessations. The latest: Sumanth Karlapudi ceased to be Additional Director on 29 Sep 2023.
AGM
Phanicare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Phanicare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 3.50 Cr registered on 30 Sep 2023 with Charge ID 100803453 was modified on 29 Feb 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 3.50 Cr with Charge ID 100803453 was registered on 30 Sep 2023.
Charges
A charge with Axis Bank Limited of Rs. 11.50 Cr registered on 04 Oct 2018 with Charge ID 100218126 was modified on 30 Sep 2023.
Ceased
Sumanth Karlapudi ceased to be Additional Director.
Appointed
Sumanth Karlapudi was appointed as Director.
Charges
A charge registered on 09 Apr 2020 via Charge ID 100335511 with Axis Bank Limited was fully satisfied on 25 Jul 2022.
Charges
A charge with Axis Bank Limited of Rs. 1.61 Cr registered on 01 Jul 2020 with Charge ID 100352373 was modified on 25 Jan 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.61 Cr with Charge ID 100352373 was registered on 01 Jul 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100335511 was registered on 09 Apr 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 11.50 Cr with Charge ID 100218126 was registered on 04 Oct 2018.
16 earlier events are in the company report.
Frequently asked questions
Phanicare Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 07 October 2003 (23+ years old) and is registered under CIN U24239TG2003PTC041815.
Phanicare Pharmaceuticals has 4 current directors:
- Sumanth Karlapudi - Director
- Vishnuvardhan Reddy Devireddy - Director
- Mallikarjuna Reddy Venati - Director
- Padma Duvvuri - Director
The latest financial statements of Phanicare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Phanicare Pharmaceuticals is 36AADCP0774G1ZG, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AADCP0774G2ZD (Andhra Pradesh).
The CIN (Corporate Identification Number) of Phanicare Pharmaceuticals is U24239TG2003PTC041815. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Phanicare Pharmaceuticals has 7 court cases on record: 3 filed by the company and 4 filed against it. Most are in the district courts.
Phanicare Pharmaceuticals was incorporated on 07 October 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Phanicare Pharmaceuticals by revenue are Allastir Private Limited, Keshar Emulsion Private Limited, Hi Tech Biosciences India Private Limited, Jai Lara Drugs Private Limited, Polydrug Laboratories Private Limited and 4 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sumanth Karlapudi ceased to be Additional Director on 29 Sep 2023. Sumanth Karlapudi was appointed as Director on 01 Oct 2022. Padma Duvvuri ceased to be Additional Director on 30 Sep 2016. Phanicare Pharmaceuticals has 10 board changes on record in total.
Yes, Phanicare Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0014345).
Phanicare Pharmaceuticals can be reached through the website phanicarepharma.com. Its registered office is in Hyderabad, Telangana, India.